Skip to main content
OpenTrials
Completed

NCT Number: NCT03250884

Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.

The aim of the study is to evaluate the effectiveness of a rapid pregnancy diagnostic test to improve the medical care of patients in emergency room.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The most current gynecological consultations in emergency unit first lead to a pregnancy diagnostic test. The gold standard used is the diagnostic test based on determination of the β-human chorionic gonadotropin concentration. But this assay need time and expect women to wait for hours. A 5-minutes pregnancy diagnostic test has been developed in France. A 62-patients study showed that results obtained with the rapid test were correlated with results obtained with the test based on determination of the β-human chorionic gonadotropin concentration.

The purpose of this study is to evaluate the efficiency of the 5-minutes pregnancy diagnostic test realized in emergency room, in comparison with the blood determination of the β-human chorionic gonadotropin concentration which is only tested in medical laboratory. A little amount of total blood sample used for gold standard test will be used to assess sensibility, specificity, positive or negative predictive values of the rapid pregnancy diagnostic test.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult women who are in genital activity
  • Women who are in emergency unit to consult for metrorrhagia and/or pelvic pains.
  • Lack of intrauterine gestational sac determined using endo-vaginal ultrasound
  • Women who need a diagnostic test using the β-human chorionic gonadotropin blood test.

Exclusion criteria

  • Previous pregnancy diagnostic assessed using the β-human chorionic gonadotropin blood test.
  • Patients included in an ovarian stimulation program for infertility
  • Ectopic gestational sac in which there is an embryo with a cardiac activity determined with ultrasound.
  • Patient objecting to participate in the study
  • Minor
  • Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.

Treatment and study plan

Primary outcomes

  1. Number of diagnostic of pregnancy with the rapid pregnancy diagnostic test in comparison with the number of diagnostic of pregnancy with the blood determination of the β-human chorionic gonadotropin concentration.

    Time frame: 6 months

    Number of diagnostic of pregnancy with the rapid pregnancy diagnostic test in comparison with the number of diagnostic of pregnancy with the blood determination of the β-human chorionic gonadotropin concentration.

Secondary outcomes

  1. Waiting time in emergency unit for patients

    Time frame: 6 months

    Waiting time in emergency unit for patients

  2. Amount of blood tests avoided with the rapid pregnancy diagnostic test

    Time frame: 6 months

    Amount of blood tests avoided with the rapid pregnancy diagnostic test

Sponsors and collaborators

Lead sponsor

Rennes University Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Aug 16, 2017
Registry last updated
Apr 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.